RLAY
Price
$3.60
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
622.35M
38 days until earnings call
XNCR
Price
$8.42
Change
+$0.12 (+1.45%)
Updated
Jul 3 closing price
Capitalization
599.26M
25 days until earnings call
Interact to see
Advertisement

RLAY vs XNCR

Header iconRLAY vs XNCR Comparison
Open Charts RLAY vs XNCRBanner chart's image
Relay Therapeutics
Price$3.60
Change-$0.00 (-0.00%)
Volume$281
Capitalization622.35M
Xencor
Price$8.42
Change+$0.12 (+1.45%)
Volume$306.91K
Capitalization599.26M
RLAY vs XNCR Comparison Chart in %
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. XNCR commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Buy and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (RLAY: $3.60 vs. XNCR: $8.42)
Brand notoriety: RLAY and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 0% vs. XNCR: 33%
Market capitalization -- RLAY: $622.35M vs. XNCR: $599.26M
RLAY [@Biotechnology] is valued at $622.35M. XNCR’s [@Biotechnology] market capitalization is $599.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 3 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than XNCR.

Price Growth

RLAY (@Biotechnology) experienced а +8.43% price change this week, while XNCR (@Biotechnology) price change was +0.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

RLAY is expected to report earnings on Aug 12, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($622M) and XNCR($599M) have the same market capitalization . RLAY YTD gains are higher at: -12.621 vs. XNCR (-63.359). XNCR has higher annual earnings (EBITDA): -161.68M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. XNCR (470M). RLAY has less debt than XNCR: RLAY (47.2M) vs XNCR (67.8M). XNCR has higher revenues than RLAY: XNCR (127M) vs RLAY (7.68M).
RLAYXNCRRLAY / XNCR
Capitalization622M599M104%
EBITDA-373.07M-161.68M231%
Gain YTD-12.621-63.35920%
P/E RatioN/AN/A-
Revenue7.68M127M6%
Total Cash710M470M151%
Total Debt47.2M67.8M70%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYXNCR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNNAX59.820.57
+0.96%
Victory Munder Multi-Cap A
PDFDX47.320.42
+0.90%
Perkins Discovery
SXPRX51.330.43
+0.84%
DWS S&P 500 Index R6
JNVSX19.010.07
+0.37%
Jensen Quality Mid Cap J
FIKVX14.02N/A
N/A
Fidelity Advisor Asset Manager 20% Z

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
N/A
XNCR - RLAY
52%
Loosely correlated
+1.45%
BCYC - RLAY
50%
Loosely correlated
N/A
IMNM - RLAY
49%
Loosely correlated
+2.43%
BDTX - RLAY
48%
Loosely correlated
-0.77%
RZLT - RLAY
46%
Loosely correlated
-0.82%
More